未登录
分享
收藏
分享
收藏
分享
收藏Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial
Chen, Li; Li, Hui; Zhang, Hao; Yang, Huawei; Qian, Jun; Li, Zhihua; Ren, Yu; Wang, Shu; Fu, Peifen; Yang, Hongjian; Liu, Yunjiang; Sun, Jing; Nie, Jianyun; Lei, Ruiwen; Yao, Yongzhong; Zhang, Anqin; Wang, Shouman; Ma, Xiaopeng; Ouyang, Zhong; Yang, Hongwei; Wu, Song-Yang; Cao, Shuo-Wen; Wang, Kun; Jiang, Aimei; Ouyang, Quchang; Pang, Da; Wei, Limin; Zha, Xiaoming; Shen, Yu; Qu, Xiangwen; Wu, Fei; Zhu, Xiaoyu; Wang, Zhonghua; Fan, Lei; Shao, Zhi-Ming
分享
收藏Efficacy and safety of perioperative chemotherapy combined with tislelizumab and trastuzumab for HER2-positive resectable gastric/gastroesophageal junction cancer (GC/EGJC): Data update from a phase II single-arm studyHER2阳性可切除胃/胃食管结合部癌(GC/EGJC)患者围手术期化疗联合替雷利珠单抗和曲妥珠单抗的疗效与安全性:一项单臂II期研究的最新数据
Wang, F.; Zhao, C.; Xia, J.; Liu, Z.; Meng, X.; Shan, Z.; Jiang, J.; Liu, X.; Li, H.; Sun, J.; Ding, C.; Zhang, H.; Liang, W.; Wang, J.; Ren, C.; Wang, Z.; Yang, X.; Li, S.
分享
收藏Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study早期三阴性乳腺癌患者 (新网球) 的新辅助蒽环类药物联合toripalimab和nab紫杉醇: 一项单臂II期研究
He, Min; Hao, Shuang; Ma, LinXiaoxi; Xiu, BingQiu; Yang, BenLong; Wang, ZeHao; Xue, JingYan; Chi, YaYun; Xiong, Min; Chen, Jiajian; Huang, XiaoYan; Liu, XiYu; Wu, SongYang; Xiao, Qin; Huang, Yan; Shui, RuoHong; Cao, AYong; Li, JunJie; Di, GenHong; Yang, WenTao; Hu, Xin; Liu, GuangYu; Yu, KeDa; Jiang, YiZhou; Wang, ZhongHua; Shao, ZhiMing; Wu, Jiong
分享
收藏
分享
收藏Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2-breast cancer: a sub-study of the MULAN umbrella trial
Zhu, Xiu-Zhi; Jin, Xi; Zhang, Hu-Yun-Long; Liu, Xiyu; Zhou, Yi-Fan; Chen, Yi-Yu; Fu, Tong; Jin, Ming-Liang; Zhao, Ya-Xin; Xie, Yi-Fan; Wang, Ruo-Xi; Wang, Zhong-Hua; Fan, Lei; Jiang, Yi-Zhou; Shao, Zhi-Ming
分享
收藏Microwave Ablation versus Surgical Resection for US-detected Multifocal T1N0M0 Papillary Thyroid Carcinoma: A 10-Center Study
Zhao, Zhen-Long; Wang, Shu-Rong; Dong, Gang; Liu, Ying; He, Jun-Feng; Shi, Li-Li; Guo, Jian-Qin; Wang, Zhong-Hua; Cong, Zhi-Bin; Liu, Li-Hong; Yang, Bei-Bei; Qu, Chun-Ping; Niu, Wen-Quan; Wei, Ying; Peng, Li-Li; Li, Yan; Lu, Nai-Cong; Wu, Jie; Yu, Ming-An
分享
收藏Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial
Zuo, Wen-Jia; Chen, Li; Shen, Yu; Wang, Zhong-Hua; Liu, Guang-Yu; Yu, Ke-Da; Di, Gen-Hong; Wu, Jiong; Li, Jun-Jie; Shao, Zhi-Ming
分享
收藏
分享
收藏
分享
收藏Pamiparib combined with surufatinib as a neoadjuvant therapy for advanced ovarian cancer patients in the entire population: Preliminary results of a prospective, exploratory, single-arm phase II clinical study
Xia, B.; Jiang, W.; Chen, J.; Chen, Y.; Shan, W.; Shen, W.; Tian, Y.; Chen, Y.; Chen, X.; Wu, W.; Ma, Y.; Wang, J.; Qi, W.; Wang, Z.; Li, X.; Huang, X.; Lin, H.; Hong, B.; Zhou, H.
分享
收藏
分享
收藏
分享
收藏Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: a multicenter, phase 2, umbrella, FUTURE trial
Shao, Zhi-Ming; Wang, Zhong-Hua; Jiang, Yi-Zhou; Liu, Yin; Zhu, Xiu-Zhi; Xiao, Yi; Wu, Song-Yang; Zuo, Wen-Jia; Yu, Qiang; Cao, A-Yong; Li, Jun-Jie; Yu, Ke-Da; Liu, Guang-Yu; Wu, Jiong; Sun, Tao; Cui, Jiuwei; Lv, Zheng; Li, Hui-Ping
分享
收藏
分享
收藏
分享
收藏
分享
收藏Updated data from FUTURE-C-PLUS: Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for advanced, immunomodulatory triple-negative breast cancer, an open-label, single-arm, phase 2 trial
Chen, Li; Jiang, Yi-Zhou; Wu, Songyang; Wu, Jiong; Di, Genhong; Liu, Guangyu; Yu, Keda; Fan, Lei; Li, Junjie; Hou, Yifeng; Hu, Zhen; Chen, Canming; Huang, Xiaoyan; Cao, Ayong; Hu, Xin; Zhao, Shen; Ma, Xiaoyan; Zhu, Xiaoyu; Zou, Jianjun; Yang, Wentao; Wang, Zhonghua; Shao, Zhi-ming
分享
收藏